Viewing Study NCT02128906

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2026-02-28 @ 8:49 PM
Study NCT ID: NCT02128906
Status: RECRUITING
Last Update Posted: 2025-03-26
First Post: 2014-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Sponsor: Christopher Wilke
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ERCC1 View
None oropharynx View
None larynx View
None hypopharynx View
None p16 View
None radiotherapy View
None docetaxel View
None cetuximab View
None cisplatin View
None EGFR View
None head and neck View